Document Detail


Effect of G-rich oligonucleotides on the proliferation of leukemia cells and its relationship with p53 expression.
MedLine Citation:
PMID:  21247336     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
G-rich oligonucleotides (GROs) can inhibit cell proliferation by inducing cell cycle arrest at S phase in tumor cell lines. GROs bind specific cellular proteins, such as nucleolin, a crucial protein interacting with P53; however, little is known about the relationship between GROs and P53. In this study, we have shown that GROs inhibited the proliferation of U937 cells (a human monocytic leukemia cell line without P53 expression) by inducing S-phase arrest. We also showed that GRO colocalized with nucleolin in U937 cells. GRO treatment induced alteration of a series of cell cycle regulatory proteins in U937 cells. Increased Cdk2 expression might promote the cells to enter S phase and subsequent decrease of Cdk2 might induce cell cycle arrest in S phase. Transfection of U937 cells with a wild-type p53 gene caused the formation of nucleolin-P53 complex, which alleviated the effect of GRO on leukemia cells. This alleviated effect is probably due to the decreased uptake of GRO.
Authors:
Lei Zhi; Jianwei Zhang; Yujiao Jia; Shilong Shan; Yan Li; Donghai Wang; Min Wang; Qing Rao; Haiyan Xing; Kejing Tang; Zheng Tian; Jianxiang Wang; Yingchang Mi
Related Documents :
21268136 - Grape seed extract upregulates p21 (cip1) through redox-mediated activation of erk1/2 a...
18542446 - Photovoltaic nanocrystal scintillators hybridized on si solar cells for enhanced conver...
4334216 - Effect of staphylococcal alpha-toxin on the fine structure of pancreatic acinar cells o...
22537746 - Nkrp1a(+) γδ and αβ t cells are preferentially induced in patients with salmonella ...
12140256 - Cell coupling and cx43 expression in embryonic mouse neural progenitor cells.
3019646 - Adenosine 3',5'-monophosphate-binding capacity in small and large ovine luteal cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-01-19
Journal Detail:
Title:  Oligonucleotides     Volume:  21     ISSN:  1557-8526     ISO Abbreviation:  Oligonucleotides     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-18     Completed Date:  2011-06-29     Revised Date:  2012-06-25    
Medline Journal Info:
Nlm Unique ID:  101188415     Medline TA:  Oligonucleotides     Country:  United States    
Other Details:
Languages:  eng     Pagination:  21-7     Citation Subset:  IM    
Affiliation:
State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Transport / genetics
Cell Division / drug effects
Cell Proliferation / drug effects
Cyclin-Dependent Kinase 2 / genetics,  metabolism
Cyclins / genetics,  metabolism
Gene Expression / drug effects
Genes, p53
Humans
Leukemia, Myeloid / genetics,  metabolism,  pathology
Oligonucleotides / chemical synthesis,  genetics,  pharmacology*
Phosphoproteins / genetics,  metabolism*
RNA-Binding Proteins / genetics,  metabolism*
S Phase / drug effects*
Transfection
Tumor Suppressor Protein p53 / genetics,  metabolism*
U937 Cells
Chemical
Reg. No./Substance:
0/Cyclins; 0/Oligonucleotides; 0/Phosphoproteins; 0/RNA-Binding Proteins; 0/Tumor Suppressor Protein p53; 0/nucleolin; EC 2.7.11.22/CDK2 protein, human; EC 2.7.11.22/Cyclin-Dependent Kinase 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cost comparison of robotic, laparoscopic, and open partial nephrectomy.
Next Document:  Engaging HIV-positive individuals in specialized care from an urban emergency department.